Previous Article | Next Article 
Molecular and Cellular Biology, July 2004, p. 6151-6161, Vol. 24, No. 14
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.14.6151-6161.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Regulation of Collagen Type I in Vascular Smooth Muscle Cells by Competition between Nkx2.5 and
EF1/ZEB1
Markella Ponticos,1 Terrence Partridge,2 Carol M. Black,1 David J. Abraham,1 and George Bou-Gharios3*
Centre for Rheumatology, Department of Medicine, University College of London, Hampstead, London NW3 2PF,1
Department of Muscle Biology, MRC-Clinical Science Centre,2
Renal Medicine, Department of Medicine, Imperial College London, London W12 ONN, United Kingdom3
Received 15 December 2003/
Returned for modification 28 January 2004/
Accepted 14 April 2004
A major component of the vessel wall of large arteries and veins is the extracellular matrix (ECM), which consists of collagens, elastin, and proteoglycans. Collagen type I is one of the most abundant of the ECM proteins. We have previously shown that the pro-collagen type I alpha 2 gene contains an enhancer which confers tissue-specific expression in the majority of collagen-producing cells, including blood vessels. In this paper, we delineate a specific vascular smooth muscle cell (vSMC) element: a 100-bp sequence around 16.6 kb upstream of the transcription start site that regulates collagen expression exclusively in vSMCs. Furthermore, we show that the expression is activated through the binding of the homeodomain protein Nkx2.5, which is further potentiated in the presence of GATA6. In contrast, this element was repressed by the binding of the zinc-finger protein
EF1/ZEB1. We propose a model of regulation where the activating transcription factor Nkx2.5 and the repressor
EF1/ZEB1 compete for an overlapping DNA binding site. This element is important in understanding the molecular mechanisms of vessel remodeling and is a potential target for intervention in vascular diseases where there is excessive deposition of collagen in the vessel wall.
* Corresponding author. Mailing address: Department of Renal Medicine, Imperial College London, Hammersmith Campus, Du Cane Rd., London W12 0NN, United Kingdom. Phone: 44 (0)208 3832306. Fax: 44 (0)208 3832062. E-mail:
g.gharios{at}imperial.ac.uk.
Molecular and Cellular Biology, July 2004, p. 6151-6161, Vol. 24, No. 14
0022-538X/04/$08.00+0 DOI: 10.1128/MCB.24.14.6151-6161.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J. J., Natarajan, R.
(2007). MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. USA
104: 3432-3437
[Abstract]
[Full Text]
-
Kedmi, M., Orr-Urtreger, A.
(2007). Differential brain transcriptome of {beta}4 nAChR subunit-deficient mice: is it the effect of the null mutation or the background strain?. Physiol. Genomics
28: 213-222
[Abstract]
[Full Text]
-
Majumdar, R., Yagubyan, M., Sarkar, G., Bolander, M. E., Sundt, T. M. III
(2006). Bicuspid aortic valve and ascending aortic aneurysm are not associated with germline or somatic homeobox NKX2-5 gene polymorphism in 19 patients. J. Thorac. Cardiovasc. Surg.
131: 1301-1305
[Abstract]
[Full Text]
-
Spoelstra, N. S., Manning, N. G., Higashi, Y., Darling, D., Singh, M., Shroyer, K. R., Broaddus, R. R., Horwitz, K. B., Richer, J. K.
(2006). The Transcription Factor ZEB1 Is Aberrantly Expressed in Aggressive Uterine Cancers.. Cancer Res.
66: 3893-3902
[Abstract]
[Full Text]
-
Ohi, T., Uehara, Y., Takatsu, M., Watanabe, M., Ono, T.
(2006). Hypermethylation of CpGs in the Promoter of the COL1A1 Gene in the Aged Periodontal Ligament. JDR
85: 245-250
[Abstract]
[Full Text]
-
Filippov, S., Koenig, G. C., Chun, T.-H., Hotary, K. B., Ota, I., Bugge, T. H., Roberts, J. D., Fay, W. P., Birkedal-Hansen, H., Holmbeck, K., Sabeh, F., Allen, E. D., Weiss, S. J.
(2005). MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. JEM
202: 663-671
[Abstract]
[Full Text]
-
Gauss, K. A., Bunger, P. L., Larson, T. C., Young, C. J., Nelson-Overton, L. K., Siemsen, D. W., Quinn, M. T.
(2005). Identification of a novel tumor necrosis factor {alpha}-responsive region in the NCF2 promoter. J. Leukoc. Biol.
77: 267-278
[Abstract]
[Full Text]